Nicole Vitullo

Filings by Nicole Vitullo span 20 companies, the busiest being Orexigen Therapeutics, Inc., Achillion Pharmaceuticals Inc and Esperion Therapeutics, Inc. We count 197 filings; the first trade dates from 18 April 2006 and the latest from 15 June 2023.

On the open market, the record shows 56 purchases worth €76.2M and 18 sales worth €7.7M. On balance, insiders were net buyers of €68.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 13 share grants and 5 option exercises.

The median purchase comes to €173k.

The newest entry dates from 16 June 2023: a share grant, in Esperion Therapeutics, Inc. The clock since the last published purchase (28 August 2013) now reads 4,805 days. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.